Opal Biosciences Ltd
Opal Biosciences Ltd is transforming from a preclinical stage biotechnology company to a revenue-generating pharmaceutical development business through its acquisition and growth of Formulytica Pty Ltd. Formulytica’s formulation manufacturing business to supplies local and overseas companies with clinical and preclinical pharmaceutical materials. The acquisition will complement Opal’s development of novel treatments for antibiotic-resistant or hard-to-treat infections and expand Formulytica’s services.
First Name
Last Name
Company
Email
Phone (including country code)
Country
Intentions Investor Service Provider Industry Participant
Comments
The choice you make above will help our platform display content that is best suited to you
Welcome to the new Wholesale Investor platform. Please use your existing log in details to access the site. Alternatively feel free to use the "Login with LinkedIn" or "Sign in with Google" buttons.
Enter your email to reset your password.